Literature DB >> 20870448

Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection.

Ellen Witte1, Katrin Witte, Katarzyna Warszawska, Robert Sabat, Kerstin Wolk.   

Abstract

Interleukin (IL)-22 is a member of the IL-10 cytokine family that is produced by special immune cell populations, including Th22, Th1, and Th17 cells, classical and non-classical (NK-22) NK cells, NKT cells, and lymphoid tissue inducer cells. This cytokine does not influence cells of the hematopoietic lineage. Instead, its target cells are certain tissue cells from the skin, liver and kidney, and from organs of the respiratory and gastrointestinal systems. The main biological role of IL-22 includes the increase of innate immunity, protection from damage, and enhancement of regeneration. IL-22 can play either a protective or a pathogenic role in chronic inflammatory diseases depending on the nature of the affected tissue and the local cytokine milieu. This review highlights the primary effects of IL-22 on its target cells, its role in the defense against infections, in tumorigenesis, in inflammatory diseases and allergy as well as the potential of the therapeutic modulation of IL-22 action.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20870448     DOI: 10.1016/j.cytogfr.2010.08.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  92 in total

Review 1.  Skin function for human CD1a-reactive T cells.

Authors:  Marco Colonna
Journal:  Nat Immunol       Date:  2010-12       Impact factor: 25.606

Review 2.  Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease.

Authors:  Ali Raza; Wajeeha Yousaf; Ralph Giannella; Mohamed Tarek Shata
Journal:  Expert Rev Clin Immunol       Date:  2012-02       Impact factor: 4.473

3.  Lipopolysaccharide downregulates macrophage-derived IL-22 to modulate alcohol-induced hepatocyte cell death.

Authors:  Yaming Liu; Vikas K Verma; Harmeet Malhi; Greg J Gores; Patrick S Kamath; Arun Sanyal; Naga Chalasani; Bin Gao; Vijay H Shah
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-21       Impact factor: 4.249

4.  A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy.

Authors:  Jin-Soon Suh; Seong H Cho; Joo-Ho Chung; Ahrim Moon; Yong-Koo Park; Byoung-Soo Cho
Journal:  J Interferon Cytokine Res       Date:  2013-05-09       Impact factor: 2.607

5.  Acute and chronic effects of IL-22 on acetaminophen-induced liver injury.

Authors:  Dechun Feng; Yan Wang; Hua Wang; Honglei Weng; Xiaoni Kong; Brittany V Martin-Murphy; Yongmei Li; Ogyi Park; Steven Dooley; Cynthia Ju; Bin Gao
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

6.  IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium.

Authors:  Ming-Jiang Xu; Dechun Feng; Hua Wang; Youfei Guan; Xiaoqiang Yan; Bin Gao
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

Review 7.  Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.

Authors:  Ning Zhang; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Cell Biochem       Date:  2011-03-08       Impact factor: 3.396

Review 8.  Cytokine crowdsourcing: multicellular production of TH17-associated cytokines.

Authors:  Kathleen O Busman-Sahay; Travis Walrath; Samuel Huber; William O'Connor
Journal:  J Leukoc Biol       Date:  2014-12-29       Impact factor: 4.962

9.  Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders.

Authors:  Marlen Vitales-Noyola; Ana M Ramos-Levi; Rebeca Martínez-Hernández; Ana Serrano-Somavilla; Miguel Sampedro-Nuñez; Roberto González-Amaro; Mónica Marazuela
Journal:  Endocrine       Date:  2017-07-01       Impact factor: 3.633

10.  IL-22 is essential for lung epithelial repair following influenza infection.

Authors:  Derek A Pociask; Erich V Scheller; Sivanarayana Mandalapu; Kevin J McHugh; Richard I Enelow; Cheryl L Fattman; Jay K Kolls; John F Alcorn
Journal:  Am J Pathol       Date:  2013-03-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.